Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Alzheimer disease: Treatment of Alzheimer disease in Down syndrome.

Costa AC.

Nat Rev Neurol. 2012 Mar 13;8(4):182-4. doi: 10.1038/nrneurol.2012.40. No abstract available.

PMID:
22410580
2.

Memantine for Alzheimer's disease.

[No authors listed]

Med Lett Drugs Ther. 2003 Sep 15;45(1165):73-4. No abstract available.

PMID:
12968123
3.

Use of memantine to treat Alzheimer's disease.

Gauthier S, Herrmann N, Ferreri F, Agbokou C.

CMAJ. 2006 Aug 29;175(5):501-2. No abstract available. Erratum in: CMAJ. 2006 Sep 26;175(7):777. Agokou, Catherine [corrected to Agbokou, Catherine].

4.

Another perspective on the memantine graphs: clinical vs. statistical significance.

Davis S.

Med Health R I. 2005 Jan;88(1):12-4; discussion 14. No abstract available.

PMID:
15779549
5.

Memantine: the next trend in academic performance enhancement?

Ota KS, Godwin T.

J Am Osteopath Assoc. 2006 Jun;106(6):358-9. No abstract available.

PMID:
16790543
6.

Vitamin E, memantine, and Alzheimer disease.

Evans DA, Morris MC, Rajan KB.

JAMA. 2014 Jan 1;311(1):29-30. doi: 10.1001/jama.2013.282835. No abstract available.

PMID:
24381966
7.

Managing discontinuation syndrome in patients with dementia.

Gauthier S.

J Psychiatry Neurosci. 2006 Jan;31(1):72. No abstract available.

8.

[Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)].

Agüera-Ortiz LF; Grupo de Investigadores del Estudio MEMORY.

Rev Neurol. 2010 Nov 1;51(9):525-34. Spanish.

PMID:
20979032
9.

[New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].

Wellhöfer B.

Dtsch Med Wochenschr. 2006 Feb 10;131(6):284. German. No abstract available.

PMID:
16463237
10.

Memantine for patients with Alzheimer disease.

Finucane TE.

JAMA. 2004 Apr 14;291(14):1695; author reply 1695. No abstract available.

PMID:
15082684
11.

[Alzheimer dementia. Memantine: value for patient and caregivers].

[No authors listed]

MMW Fortschr Med. 2009 Nov 5;151(45):44-5. German. No abstract available.

PMID:
19960725
12.

Pharmacological treatment of dementia.

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2. Review.

PMID:
22992546
13.

[Anti-dementia therapy pays at every stage of the disease. Patients with Alzheimer's disease stay all-day fit longer].

[No authors listed]

MMW Fortschr Med. 2003 May 26;145 Suppl 2:113. German. No abstract available.

PMID:
14579507
14.

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

Wilkinson D, Wirth Y, Goebel C.

Dement Geriatr Cogn Disord. 2014;37(1-2):71-85. doi: 10.1159/000353801. Epub 2013 Oct 3. Review.

PMID:
24107324
15.

Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.

Schmitt FA, van Dyck CH, Wichems CH, Olin JT; Memantine MEM-MD-02 Study Group.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62.

PMID:
17132970
16.

Dementia with cardiac problems.

Bute J, Waller D.

BMJ. 2011 Jul 22;343:d4278. doi: 10.1136/bmj.d4278. No abstract available.

PMID:
21784881
17.

[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].

Frölich L, Schmitt B, Calabrese P, Diener H, Förstl H, Gertz HJ, Hallauer JF, Hampel H, Ihl R, Rieke K, Riepe M, Supprian T.

Dtsch Med Wochenschr. 2005 Feb 25;130(8):408-12. Review. German. No abstract available.

PMID:
15717252
18.

I remember.

Ladouceur R.

Can Fam Physician. 2006 Feb;52:155. English, French. No abstract available.

19.

Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.

Riordan KC, Hoffman Snyder CR, Wellik KE, Caselli RJ, Wingerchuk DM, Demaerschalk BM.

Neurologist. 2011 Mar;17(2):121-3. doi: 10.1097/NRL.0b013e31820aa383.

PMID:
21364371
20.

Combination therapy no advantage in Alzheimer's treatment.

[No authors listed]

Harv Health Lett. 2012 Jun;37(8):8. No abstract available.

PMID:
22774260

Supplemental Content

Support Center